Given the crucial role of both RRM2 expression and RRM2K283Cr in colon cancer cells after p53 deficiency in vitro, to investigate whether their expression in vivo mirrors that observed in vitro, we performed subcutaneous xenograft and cisplatin treatment. Here, TP53 is linked to colonic neoplasm.